The role of the natural killer (NK) cell modulation in breast cancer incidence and progress
Authors:
- Ehsan RazeghianEREhsan Razeghian
- Mahdis Chahar KamehMKMahdis Chahar Kameh
- Sepehr ShafieeSSSepehr Shafiee
- Farima KhalafiFKFarima Khalafi
- Fehimeh JafariFJFehimeh Jafari
- Mohammadali AsghariMAMohammadali Asghari
- Kiarash KazemiKKKiarash Kazemi
- Saba IlkhaniSISaba Ilkhani
- Siavash ShariatzadehSSSiavash Shariatzadeh
- Arvin Haj-MirzaianArvin Haj-Mirzaian
- 25 August 2022
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (11) , 10935-10948
Abstract
The importance of the immune system on tumor surveillance has been investigated for many years, and its impact on controlling tumor progression has been verified. An important subgroup of the innate immune system is natural killer (NK) cells, whose essential function in modulating tumor behavior and suppressing metastasis and tumor growth has been demonstrated. The first idea of NK cells’ crucial biological processes was demonstrated through their potent ability to conduct direct cellular cytotoxicity, even without former sensitization. These properties of NK cells allow them to recognize transformed cells that have attenuated self-ligand and express stress-induced ligands. Furthermore, secretion of various cytokines and chemokines after their activation leads to tumor elimination via either direct cytotoxic effect on malignant cells or activation of the adaptive immune system. In addition, novel immunotherapeutic approaches tend to take advantage of NK cells’ ability, leading to antibody-based approaches, the formation of engineered CAR-NK cells, and adoptive cell transfer. However, the restricted functionality of NK cells and the inability to infiltrate tumors are its blind spots in breast cancer patients. In this review, we gathered newly acquired data on the biology and functions of NK cells in breast cancer and proposed ways to employ this knowledge for novel therapeutic approaches in cancers, particularly breast cancer.Keywords
This publication has 133 references indexed in Scilit:
- Engineering lymph node homing of ex vivo–expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7Blood, 2012
- Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicityBlood, 2012
- Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9Blood, 2012
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunityJournal of Clinical Investigation, 2011
- A signature of immune function genes associated with recurrence-free survival in breast cancer patientsBreast Cancer Research and Treatment, 2011
- Innate or Adaptive Immunity? The Example of Natural Killer CellsScience, 2011
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironmentJournal of Experimental Medicine, 2010
- CD56bright natural killer (NK) cells: an important NK cell subsetImmunology, 2009
- Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapyBreast Cancer Research, 2008
- Expression Analysis of the Ligands for the Natural Killer Cell Receptors NKp30 and NKp44PLOS ONE, 2007